Today: 22 May 2026
CoreWeave stock edges higher as new lawsuit filing and insider sale notice hit tape
22 January 2026
1 min read

CoreWeave stock edges higher as new lawsuit filing and insider sale notice hit tape

New York, Jan 22, 2026, 11:36 a.m. ET — Regular session

  • CoreWeave shares edged up roughly 1% in late morning trades following a turbulent week
  • A Form 144 filing revealed a major shareholder intends to offload roughly $26.8 million worth of shares
  • A law firm announced that a securities class action lawsuit has been filed against the company

CoreWeave shares edged up roughly 1% to $95.04 on Thursday, bouncing between $93.30 and $99.20 during the session. Investors digested new legal developments alongside a recent filing hinting at possible insider selling.

These moves are crucial given CoreWeave’s volatile intraday swings this week. The stock has grown increasingly reactive to any factor that increases supply or raises questions about disclosures.

This is particularly the case for fast-growing AI infrastructure stocks, where traders jump on filings and headlines before cash flow and capital spending figures even register.

Pomerantz LLP announced Thursday that it filed a securities class action lawsuit against CoreWeave and some of its officers in U.S. federal court in Texas. The suit targets investors who purchased CoreWeave securities from March 28, 2025, through Dec. 15, 2025.

Separately, a Form 144 filing revealed an intention to offload 281,250 shares via Morgan Stanley Smith Barney. The total market value is pegged at roughly $26.8 million, based on the filing summary. Under SEC Rule 144, affiliates must file a Form 144 when selling restricted or control securities.

The planned sale represents only a tiny fraction of the company’s 386.4 million shares outstanding, yet it follows a period marked by heavy trading activity.

CoreWeave ended Wednesday’s trading at $94.05, having dropped to a session low of $87.25 earlier, according to .

CNBC’s Jim Cramer called out the stock this week, noting, “CoreWeave’s stock is coming back,” Insider Monkey reported in a recap. Insider Monkey

The overhang remains a concern. Lawsuits tend to drag out, and if early investors start selling, it could weigh on the stock—especially since it has shown sharp drops on risk-off days.

The next major milestone for investors is CoreWeave’s upcoming quarterly report. Nasdaq currently estimates the earnings release around Feb. 9, but warns the date is algorithm-driven and subject to change.

Stock Market Today

  • Senores Pharmaceuticals Reports Strong Profits Amid Cash Flow Concerns
    May 21, 2026, 9:48 PM EDT. Senores Pharmaceuticals (NSE:SENORES) posted strong statutory profits of ₹1.16 billion for the year ending March 2026. However, its accrual ratio of 0.34 reveals a significant discrepancy, with free cash flow (FCF) actually negative at ₹2.0 billion. This suggests profits are not fully supported by cash generation, raising concerns over the company's underlying earnings quality. Analysts caution that high accruals often predict lower future profitability. Despite these cash flow issues, the company has demonstrated impressive earnings per share (EPS) growth over three years. Investors should weigh these mixed signals carefully, considering risks and other financial metrics before making decisions about the stock.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Natural gas spikes above $5 after EIA storage draw as UNG and LNG-linked stocks swing
Previous Story

Natural gas spikes above $5 after EIA storage draw as UNG and LNG-linked stocks swing

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus
Next Story

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus

Go toTop